26.95
price down icon11.20%   -3.40
after-market Handel nachbörslich: 26.50 -0.45 -1.67%
loading
Schlusskurs vom Vortag:
$30.35
Offen:
$28.49
24-Stunden-Volumen:
811.03K
Relative Volume:
4.56
Marktkapitalisierung:
$176.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-74.14M
KGV:
-2.3661
EPS:
-11.39
Netto-Cashflow:
$-65.70M
1W Leistung:
+28.21%
1M Leistung:
+129.95%
6M Leistung:
+0.15%
1J Leistung:
+144.11%
1-Tages-Spanne:
Value
$23.47
$29.62
1-Wochen-Bereich:
Value
$22.46
$35.28
52-Wochen-Spanne:
Value
$9.62
$92.00

Instil Bio Inc Stock (TIL) Company Profile

Name
Firmenname
Instil Bio Inc
Name
Telefon
(972) 499-3350
Name
Adresse
3963 MAPLE AVENUE, DALLAS
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
TIL's Discussions on Twitter

Vergleichen Sie TIL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TIL
Instil Bio Inc
26.95 137.89M 0 -74.14M -65.70M -11.39
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Instil Bio Inc Stock (TIL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-07 Hochstufung Jefferies Hold → Buy
2024-11-04 Eingeleitet JMP Securities Mkt Perform
2024-04-12 Herabstufung Jefferies Buy → Hold
2022-11-01 Herabstufung Cowen Outperform → Market Perform
2022-11-01 Herabstufung Truist Buy → Hold
2021-08-13 Eingeleitet Robert W. Baird Outperform
2021-04-13 Eingeleitet Cowen Outperform
2021-04-13 Eingeleitet Morgan Stanley Equal-Weight
2021-04-13 Eingeleitet Truist Buy
Alle ansehen

Instil Bio Inc Aktie (TIL) Neueste Nachrichten

pulisher
11:48 AM

Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock? - MSN

11:48 AM
pulisher
May 30, 2025

Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade - MSN

May 30, 2025
pulisher
May 30, 2025

Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 30, 2025
pulisher
May 30, 2025

Instil Bio CEO Reveals Latest Pipeline Updates at Prestigious Jefferies Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 28, 2025

Instil Bio Elects Director and Ratifies Auditor - TipRanks

May 28, 2025
pulisher
May 27, 2025

Instil Bio Advances Phase 2 Trial in China - TipRanks

May 27, 2025
pulisher
May 26, 2025

(TIL) Proactive Strategies - news.stocktradersdaily.com

May 26, 2025
pulisher
May 25, 2025

Instil Bio: Second Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF Success (TIL) - Seeking Alpha

May 25, 2025
pulisher
May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 By Investing.com - Investing.com South Africa

May 24, 2025
pulisher
May 24, 2025

H.C. Wainwright lifts Instil Bio stock target to $125 - Investing.com

May 24, 2025
pulisher
May 24, 2025

Instil Bio (TIL) Receives Price Target Upgrade by HC Wainwright & Co. | TIL Stock News - GuruFocus

May 24, 2025
pulisher
May 24, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following P - GuruFocus

May 24, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco Announce Joint Investor Breakfast in Chicago to Discuss Immuno-Oncology Developments - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving ... - Bluefield Daily Telegraph

May 23, 2025
pulisher
May 23, 2025

H.C. Wainwright Boosts Instil Bio (TIL) Price Target Following Positive Data Release | TIL Stock News - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Advances Clinical Trials for NSCLC Treatment | - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Shares Surge on New Clinical Development Plans - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Instil Bio stock rises on cancer trial updates (TIL:NASDAQ) - Seeking Alpha

May 22, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Maintains Buy Rating as Price Target is Adjusted | TIL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Instil Bio stock price target cut to $105 by H.C. Wainwright - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Price Target Reduced by Analyst | TIL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Instil Bio Partners with ImmuneOnco for Cancer Therapy - TipRanks

May 22, 2025
pulisher
May 22, 2025

Instil Bio (TIL) Advances Clinical Trials for NSCLC Treatment | TIL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Alerts incorrectly tagged to T Rowe Price Large-Cap Value Fund withdrawn - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 ... - Bluefield Daily Telegraph

May 22, 2025
pulisher
May 22, 2025

Instil Bio's Lung Cancer Drug Achieves 23% Response Rate in Phase 2 Trial, Major Results Expected in Late 2025 - Stock Titan

May 22, 2025
pulisher
May 20, 2025

Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews

May 20, 2025
pulisher
May 20, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

May 20, 2025
pulisher
May 20, 2025

Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga

May 20, 2025
pulisher
May 16, 2025

(TIL) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 13, 2025

Instil (TIL) Projects Financial Stability Through 2026 | TIL Sto - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Instil Bio, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 13, 2025
pulisher
May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Trading (TIL) With Integrated Risk Controls - news.stocktradersdaily.com

May 06, 2025
pulisher
Apr 28, 2025

Financial Metrics Check: Microbot Medical Inc (MBOT)’s Ratios for Trailing Twelve Months - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Investor’s Toolkit: Key Ratios for Assessing Instil Bio Inc (TIL)’s Performance - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

TIL’s Stock Market Adventure: -33.05% YTD Growth Amidst Volatility - investchronicle.com

Apr 28, 2025
pulisher
Apr 24, 2025

Have you been able to find a good deal on Instil Bio Inc’s shares? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Instil Bio Inc (TIL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Apr 24, 2025
pulisher
Apr 20, 2025

(TIL) Trading Report - news.stocktradersdaily.com

Apr 20, 2025
pulisher
Apr 14, 2025

Here's Why Summit Therapeutics Stock Soared 15% on Friday - Nasdaq

Apr 14, 2025
pulisher
Apr 08, 2025

GT’s Debt-to-Equity Ratio at 1.85: What It Means for Goodyear Tire & Rubber Co’s Future - investchronicle.com

Apr 08, 2025
pulisher
Apr 04, 2025

Where are the Opportunities in (TIL) - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Apr 01, 2025

Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally - GlobeNewswire Inc.

Apr 01, 2025
pulisher
Apr 01, 2025

Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market - GlobeNewswire

Apr 01, 2025
pulisher
Mar 31, 2025

SEC Form 424B5 filed by Instil Bio Inc. - Quantisnow

Mar 31, 2025
pulisher
Mar 25, 2025

(TIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 25, 2025
pulisher
Mar 20, 2025

The Significance of Moving Averages in New Found Gold Corp Inc. (NFGC) Price Performance - investchronicle.com

Mar 20, 2025

Finanzdaten der Instil Bio Inc-Aktie (TIL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):